VIM and prostate carcinoma: It has also been reported that cucurbitacin E exhibits specific cytotoxicity against prostate carcinoma explants, and the mechanism underlying this process is to induce disruption of the action and vimentin cytoskeleton in prostate carcinoma cells [79].